119 related articles for article (PubMed ID: 1183781)
1. Presence of immunosuppressive agents with various activities in Ehrlich ascites fluid.
Nitta K; Umezawa H
Gan; 1975 Aug; 66(4):459-60. PubMed ID: 1183781
[No Abstract] [Full Text] [Related]
2. Immunosuppression induced with cell-free fluid of Ehrlich carcinoma ascites and its fractions.
Yamazaki H; Nitta K; Umezawa H
Gan; 1973 Feb; 64(1):83-92. PubMed ID: 4577968
[No Abstract] [Full Text] [Related]
3. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
Donenko FV; Kabieva AO; Moroz LV
Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
[TBL] [Abstract][Full Text] [Related]
4. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
Donenko FV; Kabieva AO; Moroz LV
Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
[TBL] [Abstract][Full Text] [Related]
5. Immunodepression, ascites tumour and lactate dehydrogenase virus.
Vincent MD; Potter JG; Cooper S
S Afr Med J; 1977 Nov; 52(23):924-6. PubMed ID: 594855
[TBL] [Abstract][Full Text] [Related]
6. Isolation of a factor from cancer ascitic fluid increasing susceptibility of mice to Pseudomonas infection.
Umenai T; Takano S; Tanaka K; Ishida N
Proc Soc Exp Biol Med; 1980 Dec; 165(3):398-403. PubMed ID: 7465551
[No Abstract] [Full Text] [Related]
7. [Nonspecific suppressive effect of Ehrlich tumor ascitic fluid on transplantation immunity].
Belokhvostov AS; Zelenkova NK
Biull Eksp Biol Med; 1978 Oct; 86(10):474-6. PubMed ID: 361103
[TBL] [Abstract][Full Text] [Related]
8. [Resistance of ascitic fluid immunosuppressive factor DNA to pancreatic deoxyribonuclease].
Belokhvostov AS; Zelenkova NK
Biokhimiia; 1979 Apr; 44(4):711-4. PubMed ID: 435581
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of lymphocyte and macrophage from mice immunized with Ehrlich ascites tumor cells.
Sakashita T
Mie Med J; 1971 Jan; 20(3):227-41. PubMed ID: 5558109
[No Abstract] [Full Text] [Related]
10. 14C-arginine-rich basic proteins in ascitic fluid of Ehrlich tumor.
Farbiszewski R; Zdrodowska J; Kilczewska D
Neoplasma; 1981; 28(5):617-9. PubMed ID: 7312080
[TBL] [Abstract][Full Text] [Related]
11. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
Olinescu A; Hristescu S; Mazilu E
Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
[TBL] [Abstract][Full Text] [Related]
12. [Blood ammonia in mice bearing Ehrlich ascites tumors].
Carrascosa JM; Martínez P; Núñez de Castro I
Rev Esp Fisiol; 1982; 38 Suppl():195-8. PubMed ID: 7146577
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression mediated by Ehrlich ascites fluid.
Hrsak I; Marotti T
Eur J Cancer (1965); 1973 Oct; 9(10):717-24. PubMed ID: 4547707
[No Abstract] [Full Text] [Related]
14. [Effect of the nucleic acids from the ascitic fluid of Ehrlich's tumor on its transplantability].
Belokhvostov AS; Grikurova NK
Vopr Onkol; 1981; 27(12):56-9. PubMed ID: 7324403
[TBL] [Abstract][Full Text] [Related]
15. Isolation of soluble immunosuppressive substance(s) from Ehrlich ascites tumor cell nuclei.
Haba S; Hamaoka T; Masaki H; Takatsu K; Kitagawa M
Gan; 1976 Aug; 67(4):601-5. PubMed ID: 1024853
[TBL] [Abstract][Full Text] [Related]
16. [3H-thymidine incorporation into the DNA of the nucleic factor in the ascitic fluid of Ehrlich cancer].
Belokhvostov AS
Eksp Onkol; 1985; 7(6):50-3. PubMed ID: 4085399
[TBL] [Abstract][Full Text] [Related]
17. Isolation of an inhibitor of type II interferon induction from tumor ascitic fluids.
Matsubara S; Suzuki M; Nakamura M; Edo K; Ishida N
Cancer Res; 1980 Jul; 40(7):2534-8. PubMed ID: 6248207
[TBL] [Abstract][Full Text] [Related]
18. [Presence of C-particle group-specific antigens in the liquid phase of mouse ascitic tumors].
Ribacchi R
Lav Ist Anat Istol Patol Univ Studi Perugia; 1971; 31(3):91-102. PubMed ID: 4338719
[No Abstract] [Full Text] [Related]
19. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
Weiland E; Weiland F
Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
[No Abstract] [Full Text] [Related]
20. Dynamics of growth and regression of Ehrlich ascites carcinoma transplanted intraperitoneally in rats.
Janik P; Dabrowski M; Dux K
Arch Immunol Ther Exp (Warsz); 1966; 14(6):717-23. PubMed ID: 5957993
[No Abstract] [Full Text] [Related]
[Next] [New Search]
